Carrie Carter

IsoPlexis Corp. engages in the development of curative medicines and personalized therapeutics. Its single cell proteomics platform, which includes instruments, chip consumables and software, provides an end-to-end solution to reveal a more complete view of protein function at an individual cellular level. The company was founded by Sean Mackay, Rong Fan, and Kara K. Brower in March 2013 and is headquartered in Branford, CT.

Clinical Development Group provides expert drug development support through strategic consulting, and clinical trial oversight and operations. The team's global clinical trial and regulatory experience informs the rationale that they apply to construct their clinical development solutions. They provide quality deliverables and rapid turnaround because of their operational efficiency and agility. Their strong network of key investigator and academic relationships supports their success. They have developed a reputation in the field from a long history of personal interactions with industry clients, academic investigators, and vendors.